Dr. Larry I. Lipshultz, MD

Dr. Lipshultz practices at Bcm Physicians in Houston, Texas.

Dr. Lipshultz's NPI, 1811087851, was assigned on October 13, 2006. Dr. Lipshultz graduated from University of Pittsburgh School of Medicine in 1968. Dr. Lipshultz holds Texas license E5147.

Dr. Lipshultz's primary practice is Bcm Physicians, at 7200 Cambridge St, Houston, TX 77030 in Harris County. The practice phone is (713) 798-0000.

Dr. Lipshultz's primary practice is Bcm Physicians in Houston, Texas. Dr. Lipshultz is also affiliated with Baylor St. Luke's Medical Center. The medical group on file is Baylor Medicine.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lipshultz practices. Vendor and product names are available with a free account.

Urology is Dr. Lipshultz's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Lipshultz is board certified in urology by the American Board of Urology. Dr. Lipshultz is licensed in Texas.

Dmand AI lists enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney stone disease, testicular dysfunction, urinary endoscopy, urine flow blockage and UTI among the conditions Dr. Lipshultz treats.

CMS data shows 1,085 Medicare services from Dr. Lipshultz across 20 procedure codes in 2024, for 332 Medicare patients. Medicare paid $65,653 for them. Every service was in an office.

CMS counts 332 Medicare patients who saw Dr. Lipshultz in 2024. The largest group is 65 to 74, with 180 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.01, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lipshultz's median patient age at 48, with 1% women.

In 2024, Dr. Lipshultz wrote 2,169 Medicare Part D claims for 379 patients. 92% of them were for generic drugs. CMS names the drug for 1,942 of them, across 27 drugs with 11 or more claims each, at $188,169 in total drug cost. In 2023, CMS named 1,864 claims across 25 drugs.

Dr. Lipshultz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lipshultz as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 360 papers to Dr. Lipshultz, published from 2007 to 2025. 2016 was the busiest year, with 14. The most frequent topics are Infertility, Male, Testosterone and Hypogonadism. Dr. Lipshultz has published most often in Fertil Steril. Dr. Lipshultz's most frequent co-authors are Ranjith Ramasamy, MD, Mohit Khera, MD and Taylor Poteet Kohn, MD.

Dmand AI links Dr. Lipshultz to 4 clinical trials, 2 of them early phase 1 studies. Conditions studied include Hypogonadism, Erectile Dysfunction and Eunuchism. Baylor College of Medicine sponsors the most, 2.

CMS Open Payments shows 399 general payments to Dr. Lipshultz from 26 drug and device companies from 2016 to 2025. Honoraria make up the largest share, 29% of the total. Boston Scientific Corporation paid the most, $15,261.

Dmand AI lists 6 awards for Dr. Lipshultz, most recently America's Top Doctors in 2014.

Dr. Lipshultz graduated from University of Pittsburgh School of Medicine in 1968. Dr. Lipshultz is a member of ACS.

Dr. Lipshultz is in network with 21 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.